StockOrNot
Open the deck

HCA Healthcare (HCA)

Health Care · $106B market cap · SEC CIK 0000860730

$504.42 ▼−0.09% on the day close of Nov 10, 2026
88 Screens strongly
ahead of 88% of the S&P 500 · #10 of 59 in Health Care

Next reports on Jan 25, 2027, after the close, with analysts expecting $8.28 in earnings per share.

52-week range $353.99 to $556.52. 9% below its 52-week high and 42% above its low.

The case for HCA

The case against

What the score is made of

Each factor is half a curve over reported figures and half a rank among the other Health Care companies (momentum is judged against fixed thresholds only), and the five are blended by weight. The score is where that blend places it in the S&P 500. It describes the last filing and the current price. It is not a forecast.

Valuewhat you pay for the earnings and cash, against the growth you get88
Growthhow fast revenue and earnings are moving, this year and over five66
Profitabilityhow much of the revenue becomes profit, and how much of that is cash66
Momentumhow the price has behaved lately72
Stabilityhow violently it moves, what it owes and what it pays you33

The financials

Revenue growth

Is the business growing? Slowly

Last 12 months+5.8%
Over 5 years+8.0% a year
FY2025 revenue$75.6B (+7%)

Free cash flow

Is it generating real cash? Yes

FY2025 free cash flow$7.7B
Of revenue10%
Of profit113%

Profit margins

Is profitability improving? Holding steady

Gross margin85%
Operating margin15%
Net margin, FY24 → FY25 → now8.2% → 9.0% → 8.6%

Debt vs. cash

Is the balance sheet healthy? Stretched

Cash$1.0B
Long-term debt$41.6B
Net debt$40.6B
Years to repay3.3 yrs

Valuation

Is the stock price reasonable? Yes, it looks cheap

P/E15.6×
Fair P/E for its growth27×
P/FCF13.7×
Forward P/E15.2×
EV / EBITDA9.8×

At 15.6× earnings it trades well below the 27× that 12% a year of growth plus a 1.0% dividend would justify. At 13.7× free cash flow it trades well below that same mark.

The financials, five years deep

Pulled from HCA Healthcare's XBRL filings on SEC EDGAR. Italic rows are worked out from the others.

FY2025FY2024FY2023FY2022FY2021
Revenue growth
Revenue$75.6B$70.6B$65.0B$60.2B$58.8B
Change on the year+7%+9%+8%+3%—
Free cash flow
Free cash flow$7.7B$5.6B$4.7B$4.1B$5.4B
Of revenue10%8%7%7%9%
Profit margins
Net margin9.0%8.2%8.1%9.4%11.8%
Debt vs. cash
Cash$1.0B$1.9B$935M$908M$1.5B
Long-term debt$41.6B$38.3B$37.2B$37.7B$34.3B
Net cash (debt)−$40.6B−$36.4B−$36.2B−$36.8B−$32.9B

What HCA Healthcare says it does

HCA Healthcare, Inc. is one of the leading health care services companies in the United States. At December 31, 2025, we operated 190 hospitals, comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals. In addition, we operated 121 freestanding ambulatory surgery centers (“ASCs”) and 31 freestanding endoscopy centers. Our facilities are located in 19 states and England. The terms “Company,” “HCA,” “HCA Healthcare,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Healthcare, Inc. and its affiliates. The term “affiliates” means direct and indirect subsidiaries of HCA Healthcare, Inc. and partnerships and joint ventures in which such subsidiaries are partners. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA, and the term “employees” refers to employees of affiliates of HCA. Our primary…

Risk factors HCA lists in its 10-K

Filings

Open HCA in the deck

Other Health Care companies

LLYEli LillyJNJJohnson & JohnsonABBVAbbVieMRKMerck & Co.UNHUnitedHealth GroupTMOThermo Fisher ScientificAMGNAmgenGILDGilead SciencesABTAbbott LaboratoriesPFEPfizerDHRDanaherISRGIntuitive Surgical